Prothrombinase induced clotting time (PiCT®) for measuring the activity of direct factor Xa inhibitors in clinical setting

被引：0
|
作者：
Olivera, P. E. [1 ]
Cortina, V [1 ]
Pons, V [1 ]
Merchan, B. [2 ]
Lopez-Andreoni, L. [1 ]
Artaza, G. [1 ]
Menino, E. [3 ]
Marin, A. [2 ]
Bosch, F. [2 ]
Santamaria, A. [1 ]
机构：
[1] Univ Hosp Vall dHebron, Hemostasis & Thrombosis Unit, Barcelona, Spain
[2] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain
[3] Primary Healthcare Ctr Rio de Janeiro Prosperitat, Barcelona, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO375-TUE
引用
收藏
页码：643 / 643
页数：1
相关论文
共 50 条
  • [21] Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
    Verhoef, Daniel
    Visscher, Koen M.
    Vosmeer, C. Ruben
    Cheung, Ka Lei
    Reitsma, Pieter H.
    Geerke, Daan P.
    Bos, Mettine H. A.
    NATURE COMMUNICATIONS, 2017, 8
  • [22] Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors
    Daniël Verhoef
    Koen M. Visscher
    C. Ruben Vosmeer
    Ka Lei Cheung
    Pieter H. Reitsma
    Daan P. Geerke
    Mettine H. A. Bos
    Nature Communications, 8
  • [23] Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a
    Graff, J.
    Picard-Willems, B.
    Harder, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (04) : 237 - 243
  • [24] Measuring the anticoagulant effect of direct factor Xa inhibitors. Is the anti-Xa assay preferable to the prothrombin time test?
    Tripodi, Armando
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (04) : 735 - 736
  • [25] Prothrombinase Induced Clotting Time (PICT) and Commercially Available Diluted Russell's Viper Venom Times For The Monitoring Of New Oral Anticoagulants
    Hoppensteadt, Debra
    Walenga, Jeanine M.
    Cunanan, Josephine
    Iqbal, Omer
    Fareed, Jawed
    BLOOD, 2013, 122 (21)
  • [26] Direct factor Xa and thrombin inhibitors: clinical trial update
    Turpie, A. G. G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 499 - 499
  • [27] Oral Factor Xa and Direct Thrombin Inhibitors: A Clinical Perspective
    Thethi, Indermohan
    Lewis, Bruce
    Fareed, Jawed
    JOURNAL OF BURN CARE & RESEARCH, 2012, 33 (04): : 453 - 461
  • [28] Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
    Barrett, Yu Chen
    Wang, Zhaoqing
    Frost, Charles
    Shenker, Andrew
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) : 1263 - 1271
  • [29] Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa-Inhibitors
    Verhoef, Danil
    Schreuder, Mark
    Cheung, Ka Lei
    Reitsma, Pieter H.
    Bos, Mettine H. A.
    BLOOD, 2015, 126 (23)
  • [30] Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation
    Stewart, Ralph A. H.
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 (04) : 294 - 299
12345